Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.

Sophie Park Charikleia Kelaidi Mathieu Meunier Nicole Casadevall Aaron T Gerds Uwe Platzbecker

Ann Hematol

Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Leipzig, Germany.

Published: January 2020

This article was originally published without an Open Access but due to the authors final decision to opt for Open Choice this correction was created.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944644	PMC
http://dx.doi.org/10.1007/s00277-019-03874-w	DOI Listing

Publication Analysis

Top Keywords

correction prognostic

prognostic serum

serum erythropoietin

erythropoietin patients

patients lower-risk

lower-risk myelodysplastic

myelodysplastic syndromes

syndromes review

review literature

literature expert

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!